Literature DB >> 30796693

Abundance of Synaptic Vesicle-Related Proteins in Alpha-Synuclein-Containing Protein Inclusions Suggests a Targeted Formation Mechanism.

Amellia McCormack1, Damien J Keating2, Nusha Chegeni1, Alex Colella1,3, Jing Jing Wang3, Tim Chataway4.   

Abstract

Proteinaceous α-synuclein-containing inclusions are found in affected brain regions in patients with Parkinson's disease (PD), Dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). These appear in neurons as Lewy bodies in both PD and DLB and as glial cytoplasmic inclusions (GCIs) in oligodendrocytes in MSA. The role they play in the pathology of the diseases is unknown, and relatively little is still known about their composition. By purifying the inclusions from the surrounding tissue and comprehensively analysing their protein composition, vital clues to the formation mechanism and role in the disease process may be found. In this study, Lewy bodies were purified from postmortem brain tissue from DLB cases (n = 2) and GCIs were purified from MSA cases (n = 5) using a recently improved purification method, and the purified inclusions were analysed by mass spectrometry. Twenty-one percent of the proteins found consistently in the GCIs and LBs were synaptic-vesicle related. Identified proteins included those associated with exosomes (CD9), clathrin-mediated endocytosis (clathrin, AP-2 complex, dynamin), retrograde transport (dynein, dynactin, spectrin) and synaptic vesicle fusion (synaptosomal-associated protein 25, vesicle-associated membrane protein 2, syntaxin-1). This suggests that the misfolded or excess α-synuclein may be targeted to inclusions via vesicle-mediated transport, which also explains the presence of the neuronal protein α-synuclein within GCIs.

Entities:  

Keywords:  Glial cytoplasmic inclusion; Lewy body; Mass spectrometry; Multiple system atrophy; Parkinson’s disease; Vesicle trafficking

Mesh:

Substances:

Year:  2019        PMID: 30796693     DOI: 10.1007/s12640-019-00014-0

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  14 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 2.  Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.

Authors:  Tapan Behl; Sachin Kumar; Ziyad M Althafar; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vishnu Nayak Badavath; Shivam Yadav; Saurabh Bhatia; Ahmed Al-Harrasi; Yosif Almoshari; Mohannad A Almikhlafi; Simona Bungau
Journal:  Mol Neurobiol       Date:  2022-05-03       Impact factor: 5.590

3.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

Review 4.  Fluid markers of synapse degeneration in synucleinopathies.

Authors:  Alba Cervantes González; Olivia Belbin
Journal:  J Neural Transm (Vienna)       Date:  2022-02-11       Impact factor: 3.575

5.  Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure.

Authors:  Katerina Konstantoulea; Patricia Guerreiro; Meine Ramakers; Nikolaos Louros; Liam D Aubrey; Bert Houben; Emiel Michiels; Matthias De Vleeschouwer; Yulia Lampi; Luís F Ribeiro; Joris de Wit; Wei-Feng Xue; Joost Schymkowitz; Frederic Rousseau
Journal:  EMBO J       Date:  2021-11-29       Impact factor: 11.598

Review 6.  Dopaminergic Axons: Key Recitalists in Parkinson's Disease.

Authors:  Abhishek Kumar Mishra; Anubhuti Dixit
Journal:  Neurochem Res       Date:  2021-10-12       Impact factor: 3.996

7.  Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome.

Authors:  Suzanne L Dekker; Joris C J van der Lienden; Wouter Huiting; Rafaella Mergener; Maiara K Musskopf; Gabriel V Furtado; Emma Gerrits; David Coit; Mehrnoosh Oghbaie; Luciano H Di Stefano; Hein Schepers; Maria A W H van Waarde-Verhagen; Suzanne Couzijn; Lara Barazzuol; John LaCava; Harm H Kampinga; Steven Bergink
Journal:  Elife       Date:  2022-02-24       Impact factor: 8.140

Review 8.  Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology.

Authors:  Nicholas P Marotta; Virginia M-Y Lee
Journal:  Curr Opin Neurobiol       Date:  2022-02-04       Impact factor: 7.070

9.  Autofluorescence-based analyses of intranuclear inclusions of Fragile X-associated tremor/ataxia syndrome.

Authors:  Lisa Ma; Paul J Hagerman
Journal:  Biotechniques       Date:  2020-06-03       Impact factor: 1.993

Review 10.  Exosome Circuitry During (De)(Re)Myelination of the Central Nervous System.

Authors:  Helena S Domingues; Ana Mendanha Falcão; Inês Mendes-Pinto; António J Salgado; Fábio G Teixeira
Journal:  Front Cell Dev Biol       Date:  2020-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.